Atlas Trials

Study of N-homocysteinylation of Key Proteins in Alzheimer's Disease (HO-MA)

Clinical trial NCT06168955 · UNKNOWN

Trial details

NCT number
NCT06168955
Sponsor
Central Hospital, Nancy, France
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2024-02-01
Primary completion
2025-12-01
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.